Answers are grounded in this paper and cite their sources.
Background Bronchopulmonary dysplasia (BPD) remains the most common chronic respiratory disease in preterm infants, and accumulating evidence implicates the gut–lung axis in its pathogenesis. However, prospective longitudinal data linking early gut microbiota dynamics to the onset of BPD are scarce. This study aimed to characterise gut microbiota dynamics within the first 28 days of life in preterm infants of ≤ 32 weeks’ gestation and to evaluate their association with BPD and probiotic exposure. Methods Fifty preterm infants (≤ 32 weeks’ gestation) were enrolled prospectively and allocated to four groups according to BPD status and probiotic use (n = 12–13 per group). Faecal samples were collected at days 0, 3, 14, and 28 after birth and at days 7, 14, and 21 after the start of probiotic administration (seven time points). The V3–V4 region of the 16S rRNA gene was sequenced, and amplicon sequence variants were generated with QIIME2/DADA2 and annotated against SILVA 138.1. α-Diversity (Chao1, Shannon and Simpson indices) and the relative abundance of Bifidobacterium were assessed, with Benjamini–Hochberg false discovery rate (FDR) correction applied to multiple comparisons. Results The Chao1 index dropped sharply from 375.7 ± 27.2 at day 0 to 15.5 ± 0.8 at day 3 (a decrease of 95.7%), then plateaued at a low level. From day 14 onwards, α-diversity was significantly higher in the non-BPD than in the BPD groups (Chao1: 15.18 ± 0.74 vs 14.06 ± 0.71, P = 0.001 at day 14), and this difference persisted until day 28. Probiotic intervention partially reduced but did not eliminate the between-group diversity deficit. After probiotic administration, the relative abundance of Bifidobacterium was higher in the non-BPD + probiotics group than in the BPD + probiotics group at day 14 (0.0241 ± 0.0136 vs 0.0151 ± 0.0058, P = 0.041) and day 21 (0.0400 ± 0.0128 vs 0.0285 ± 0.0111, P = 0.022). Conclusions The gut microbiota of preterm infants follows a three-stage pattern of high baseline, sharp decline, and subsequent differentiation. Infants who develop BPD show sustained reductions in diversity and delayed Bifidobacterium colonisation from day 14 onward. Probiotics partially improved diversity but did not fully correct BPD-associated dysbiosis. Day 14 may represent a critical window for microbiota-directed intervention.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: